Table 1 Demographic data for the 192 subjects who reported on day of study
Group 1 | Group 2 | Group 3 | Group 4 | Group 5 Stand-bys | Total | p-values (global test of all 5 groups)* | Validation groups (Groups 1, 2 and 3) | |
|---|---|---|---|---|---|---|---|---|
Number of participants | 36 | 36 | 36 | 36 | 48 | 192 | 108 | |
Age: mean (± SD) | 68.8 (1.4) | 68.7 (1.5) | 68.5 (1.5) | 68.3 (1.5) | 68.7 (2.4) | 68.6 (1.7) | 0.619 | 68.7 (1.5) |
Sex: N (%) | 0.530 | |||||||
M | 15 (41.7%) | 20 (55.6%) | 15 (41.7%) | 19 (52.8%) | 27 (56.3%) | 96 (50%) | 50 (46.3%) | |
F | 21 (58.3%) | 16 (44.4%) | 21 (58.3%) | 17 (47.2%) | 21 (43.7%) | 96 (50%) | 58 (53.7%) | |
BMI: mean (± SD) | 28.5 (4.3) | 29.2 (4.7) | 29.2 (4.0) | 29.0 (5.2) | 29.3 (4.9) | 29.1 (4.6) | 0.956 | 29.0 (4.3) |
< 25: N (%) | 5 (13.9%) | 7 (19.4%) | 2 (5.6%) | 5 (13.9%) | 11 (22.9%) | 30 (15.6%) | 0.455 | 14 (13.0%) |
25 – < 30: N (%) | 19 (52.8%) | 16 (44.4%) | 19 (52.8%) | 18 (50.0%) | 16 (33.3%) | 88 (45.8%) | 54 (50.0%) | |
>= 30: N (%) | 12 (33.3%) | 13 (36.1%) | 15 (41.7%) | 13 (36.1%) | 21 (43.8%) | 74 (38.5%) | 40 (37.0%) | |
WHR: mean (± SD) | 0.91 (0.09) | 0.93 (0.09) | 0.91 (0.08) | 0.95 (0.09) | 0.92 (0.08) | 0.92 (0.09) | 0.408 | 0.92 (0.09) |
M | 0.97 (0.05) | 1.0 (0.04) | 0.99 (0.07) | 1.0 (0.06) | 0.97 (0.07) | 0.99 (0.05) | ||
F | 0.86 (0.09) | 0.84 (0.05) | 0.86 (0.05) | 0.89 (0.07) | 0.87 (0.05) | 0.86 (0.06) | ||
Smoker status: N (%) | ||||||||
Active smoker | 3 (8.3%) | 3 (8.3%) | 4 (11.1%) | 7 (19.4%) | 6 (12.5%) | 23 (12.0%) | 0.538 | 10 (9.3%) |
Former smoker | 17 (47.2%) | 17 (47.2%) | 10 (27.8%) | 11 (30.6%) | 19 (39.6%) | 74 (38.5%) | 44.(40.7%) | |
Non-smoker | 16 (44.4%) | 16 (44.4%) | 22 (61.1%) | 18 (50.0%) | 23 (47.9%) | 95 (49.5%) | 54 (50.0%) | |
Hypertension: N (%) | ||||||||
Yes | 20 (57.1%) | 20 (57.1%) | 21 (60.0%) | 20 (55.6%) | 34 (70.8%) | 115 (60.8%) | 0.571 | 61 (58.1%) |
No | 15 (42.9%) | 15 (42.9%) | 14 (40.0%) | 16 (44.4%) | 14 (29.2%) | 74 (39.2%) | 44 (41.9%) | |
Missing | 1 | 1 | 1 | 0 | 0 | 3 | 3 | |
Hypercholesterolemia: N (%) | ||||||||
Yes | 18 (52.9%) | 16 (45.7%) | 23 (65.7%) | 16 (55.2%) | 21 (48.8%) | 94 (53.4%) | 0.501 | 57 (54.8%) |
No | 16 (47.1%) | 19 (54.3%) | 12 (34.3%) | 13 (44.8%) | 22 (51.2%) | 82 (46.6%) | 47 (45.2%) | |
Missing | 2 | 1 | 1 | 7 | 5 | 16 | 4 | |
Diabetes: N (%) | ||||||||
Yes | 4 (11.1%) | 7 (19.4%) | 6 (16.7%) | 5 (13.9%) | 11 (22.9%) | 33 (17.2%) | 0.673 | 17 (15.7%) |
No | 32 (88.9%) | 29 (80.6%) | 30 (83.3%) | 31 (86.1%) | 37 (77.1%) | 159 (82.8%) | 91 (84.3%) | |
Vascular-widening procedures (n): N (%) | ||||||||
Yes | 0 (0%) | 1 (2.8%) | 0 (0%) | 2 (5.6%) | 3 (6.5%) | 6 (3.2%) | 0.359 | 1 (0.9%) |
No | 36 (100%) | 35 (97.2%) | 36 (100%) | 34 (94.4%) | 43 (93.5%) | 184 (96.8%) | 107 (99.1%) | |
Missing | 0 | 0 | 0 | 0 | 2 | 2 | 0 |